Microfluidics Company Market Increasing prevalence of chronic diseases like HIV, cancer, diabetes, cardiovascular diseases, brain disorders and technological advancement are key drivers responsible for the growth of Microfluidics Market.
Microfluidics is that the study of systems which will method little quantities of fluids by victimization tiny channels having dimensions at the microscale – generally tens to many micrometers. Though within the emerging stage, microfluidics is quickly rising as a breakthrough technology that finds applications in various fields starting from biology and chemistry to info technology and optics.
As additional and more researchers understand the ability of microfluidics, the technology is being applied to several new fields therefore saving cash and time spent in analysis. Despite the compelling benefits of microfluidics, it's not being wide used however – this can be probably due to the challenges within the development of this technology.
Microfluidics is that the science of fluids on the micro- and nanometre scale. However, compared to classical hydraulics, the length scales in microfluidic systems are considerably smaller. there's no clear necessity on once a system is thought-about as being microfluidic. In general, if one in every of the characteristic length scales, e.g., the peak or breadth of a fluid system options dimensions within the micrometer vary or below, such a system is thought of a microfluidic system. At these length scales, the fluid physics is completely different from what we have a tendency to are accustomed seeing in larger scale systems. As associate example, microfluidic flows are typically strictly bedded. streamline flow is rare in macroscopic systems. At AN example, think about a watercourse or maybe a coast. The water in these systems sometimes flows underneath flow conditions. this is often one thing we have a tendency to seldom see in microfluidic systems.
Another necessary side of microfluidic flows is effects of physical phenomenon. surface tension is sometimes an impact not important for megascopic fluidic systems. However, in microfluidics, attractive force forces are typically negligible because of the very fact that the number of liquids used is therefore tiny. physical phenomenon becomes predominant, e.g., in systems that transport liquids within the type of single droplets on open surfaces or inside closed channels.
As we'll see, the elemental laws of hydraulics are valid for microfluidics likewise. However, because of the very fact that effects like fluid turbulence, gravity, and also the like will typically be neglected, the equations describing microfluidic systems are usually considerably simplified versions of the equations of fluid physics. This makes microfluidic a beautiful discipline for the study of the properties and dynamics of fluid flow wherever effects, such as, diffusion, is studied at terribly high resolution.
erkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally.
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
RainDance Technologies, Inc.
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems.
Based outside Boston, Massachusetts, the company supports customers using RainDrop Plus™ Digital PCR and ThunderStorm® Next-Generation Sequencing Target Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and ThunderStorm System in 2011.
Hoffmann La-Roche Ltd
We have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.
We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies.
By Product Type
By End User
Interested in this report?
18 Feb 2021